ArticleProtein expression and purification2025
Efficient production of human mitochondrial chaperonin (Hsp60/Hsp10) in Escherichia coli using a polyprotein strategy.
Article in Protein expression and purification, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chaperonin in health and disease.Molecular biomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Escherichia coli remains the leading platform for recombinant protein production, yet co-expression of multiprotein complexes often suffers from stoichiometric imbalance, presenting a persistent challenge to precise subunit assembly. Many important biological functions are performed not by single proteins but by multiprotein complexes. Studying the structure and function of multiprotein complexes would be greatly facilitated if they could be reliably overproduced in heterologous host organisms. Here, we describe a simple method for the production of the human mitochondrial chaperonin (Hsp60/Hsp10) in Escherichia coli. Rather than producing the two chaperonin subunits from a polycistronic mRNA, a strategy commonly employed by bacterial operons, we chose to make them in the form of a single polyprotein that is subsequently cleaved inside bacterial cells by tobacco vein mottling virus (TVMV) protease. In this way, equimolar amounts of mature Hsp60 and Hsp10 subunits could be ensured. The TVMV protease is produced from a second mRNA that is transcribed from the same plasmid. Although expressed at a much lower level than the polyprotein, enough TVMV protease is produced to cleave all of the Hsp10/Hsp60 fusion protein in vivo. Moreover, we show that the mitochondrial chaperonin is fully functional when produced in this manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.